Request Demo
Recent blog posts
Latest Hotspot
9 min read
Hangzhou Atom Therapeutics Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Hangzhou Atom Therapeutics Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach r
Latest Hotspot
9 min read
Halia Therapeutics, Inc. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Halia Therapeutics, Inc.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.
Latest Hotspot
9 min read
Hainan Dermavon Pharmaceutical Technology Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Hainan Dermavon Pharmaceutical Technology Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals
Latest Hotspot
9 min read
Haihe Biopharma Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Haihe Biopharma Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.
Latest Hotspot
9 min read
Hackensack Meridian Health, Inc. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Hackensack Meridian Health, Inc.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach ratio
Latest Hotspot
8 min read
Gubra A/S Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Gubra A/S: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.
Latest Hotspot
9 min read
Guangzhou Yipinhong Pharmaceutical Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Guangzhou Yipinhong Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and ou
Latest Hotspot
9 min read
Guangzhou Virotech Pharmaceutical Co Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Guangzhou Virotech Pharmaceutical Co Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outre
Latest Hotspot
9 min read
Guangzhou Lupeng Pharmaceutical Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Guangzhou Lupeng Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outre
Latest Hotspot
9 min read
Guangzhou Bosto Controlled-Release Pharmaceutical Co Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Guangzhou Bosto Controlled-Release Pharmaceutical Co Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial s
Latest Hotspot
9 min read
Guangdong Yinzhu Pharmaceutical Technology Co., Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Guangdong Yinzhu Pharmaceutical Technology Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signal
Latest Hotspot
9 min read
Guangdong Shuanglin Biological Pharmaceutical Co. Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist — 27 Aug 2026 Edition
27 August 2026
2026 BD opportunity scan for Guangdong Shuanglin Biological Pharmaceutical Co. Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial sign